Workflow
Enphase Energy Announces Expanded Deployments of IQ Microinverters and IQ Batteries Manufactured in the United States
GlobeNewswire· 2025-05-01 12:00
Enphase has deployed more than 6.5 million IQ Microinverters and 50 MWh of IQ Batteries manufactured in the U.S. with domestic and imported componentsFREMONT, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced it has shipped more than 6.5 million IQ® Microinverters and 50 MWh of IQ® Batteries from U.S. contract manufacturing facilities. Approximatel ...
Apollo Closes its Debut Secondaries Fund at $5.4 Billion, Exceeding Target
GlobeNewswire· 2025-05-01 12:00
Brings Total Capital Raised Across Apollo S3 Platform to Nearly $10 Billion Since 2022 LaunchNEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced the final close of Apollo S3 Equity and Hybrid Solutions Fund I (“ASEHS” or the “Fund”), the flagship equity secondaries drawdown strategy of Apollo’s Sponsor and Secondary Solutions (S3) platform, with approximately $5.4 billion in commitments. The final closing exceeded the target, reflecting strong support from a diverse group of global ...
LM Funding America Announces First Quarter 2025 Earnings Call for May 15, 2025
GlobeNewswire· 2025-05-01 12:00
TAMPA, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin mining and technology-based specialty finance company, today announced that it has scheduled its first quarter 2025 earnings conference call and webcast for Thursday, May 15, 2025 at 8:00 AM EST. LM Funding will publish its first quarter 2025 results as well as an accompanying investor presentation the morning of May 15, 2025 before the call. A copy of the earnings release and inv ...
Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement into Phase 2 Biomarker Trial for Patients with Fuchs Endothelial Corneal Dystrophy
GlobeNewswire News Room· 2025-05-01 12:00
CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced favorable data from a Phase 1 single- and multiple-ascending dose (SAD/MAD) trial of DT-168 in healthy volunteers, which will be presented on May 2, 2025 at Eyecelerator @ Park City 2025, an event backed by the American Academy of Ophthalmology highlighting industry advancements and innovative new ...
AgEagle Aerial Systems Showcases eBee VISION and eBee TAC Capability to European Customers
GlobeNewswire· 2025-05-01 12:00
Unmanned Aerial Systems (UAS) manufacturer fields demonstrations for decision makers in Baltic states to answer region’s defense and public safety needs WICHITA, Kan., May 01, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of best-in-class unmanned aerial systems (UAS) and sensors for military, public safety, and commercial use, partnered with F9 Distribution Baltic to host Drone Days, a week-long event showcasing the cutting-edge capabilities of the eBee VISION and eB ...
BrainsWay to Showcase Deep TMS at the 2025 American Psychiatric Association Annual Meeting in Los Angeles
GlobeNewswire· 2025-05-01 12:00
Exhibit Booth Demonstrations and Participation in Expert Master Course Highlight BrainsWay’s Expanding Role in Psychiatric CareBURLINGTON, Mass. and JERUSALEM, May 01, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, is proud to announce its participation at the American Psychiatric Association (APA) Annual Meeting, taking place May 17–21, 2025, in Los Angeles, California. As part of the meeting’s ...
Tejon Ranch Co. to Participate in Oppenheimer’s 20th Annual Industrial Growth Conference
GlobeNewswire· 2025-05-01 12:00
TEJON RANCH, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today announced that it will participate at Oppenheimer’s 20th Annual Growth Conference (virtual format) on Tuesday, May 6, 2025. Tejon’s new President & CEO Matthew Walker is scheduled to present at 12 PM ET on May 6th. A webcast of the presentation, as well as a 90-day replay, will be available at the following webcast link: TRC Prese ...
electroCore’s Truvaga™ Now Works with the Apple Health app
GlobeNewswire· 2025-05-01 12:00
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health app. Truvaga Plus is a hand-held vagus nerve stimulator designed to elevate the day-to-day experience through quick and gentle activation of your vagus nerve. The product is designed to provide stress relief, improve sleep, enhance peace of mind and improve focus. D ...
Metalsource provides update on exploration at Aruba
GlobeNewswire· 2025-05-01 12:00
VANCOUVER, BRITISH COLUMBIA, May 01, 2025 (GLOBE NEWSWIRE) -- METALSOURCE MINING INC. (the “Company” or "Metalsource") (CSE: “MSM”) is pleased to provide an update on the Company’s exploration program at the Aruba Property, which is currently underway. This first program conducted by the company consists of a soil sampling program and a ground gravity survey. The intent is to delineate anomalous trends with coincident geophysical signatures to develop drill targets in the Transvaal Supergroup stratigraphy k ...
Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights
GlobeNewswire· 2025-05-01 12:00
Akebia to Host Conference Call on May 8, 2025, at 8:00 a.m. EDTCAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, prior to the open of financial markets. Akebia will host a conference call on Thursday, May 8, 2025, at 8:00 a.m. EDT to discuss its financial results and recent business highlights. To access the call, please register by clicking ...